查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301102

臨床試驗用品市場規模、份額和趨勢分析報告：按臨床階段、按產品/服務、按最終用途、按治療用途、按地區、細分趨勢，2023-2030 年

Clinical Trial Supplies Market Size, Share & Trends Analysis Report By Clinical Phase (Phase I, Phase II, Phase III), By Product & Services, By End-Use, By Therapeutic Use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 123 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗用品市場增長和趨勢

根據 New GrandView Research, Inc. 的報告，全球臨床試驗用品市場規模預計從 2023 年到 2030 年將以 6.5% 的複合年增長率擴大，到 2030 年將達到 34 億美元。

臨床試驗數量的增加和試驗實施的複雜性的增加是推動市場增長的主要因素。

在全球範圍內，慢性病患病率的上升和人口的迅速老齡化預計將推動生物製品研發的增長，進一步推動對高效臨床用品的需求，並增加臨床檢測用品行業的增長。 此外，孤兒藥需求的增加以及罕見病研發的高投入也有望促進生物製劑的發展。 由於這些因素，該細分市場可能在預測期內出現顯著增長。

例如，2022年諾華公司在研發方面投入了約100億美元。 它還在歐盟（EU）、日本、中國和美國獲得了23項新藥和罕見疾病的批准。 印度還有44個正在進行的III期項目，包括非典型溶血性尿毒症綜合徵（aHUS）、免疫性血小板減少性紫癜（ITP）、脊髓性肌萎縮症（SMA）、狼瘡性腎炎等罕見疾病的臨床項目17個。

直接面向患者（DTP）是有望成為未來臨床試驗藥物分銷的分銷模式的一個細分市場。 DTP 是較新的模式之一，直接向患者提供藥物並進行以患者為中心的試驗。 這減少了訪問研究地點的次數，減輕了參與者的負擔。 COVID-19 的爆發導致越來越多地採用此類模型來繼續臨床試驗研究，同時將乾擾降至最低。 此外，全球範圍內的患者保留率和多樣化的患者庫是該模型採用率高的一些主要原因。

臨床試驗用品市場報告要點

  • 從臨床階段來看，預計 2022 年 III 期試驗將主導市場，佔銷售份額的 52.7%。 目前處於 III 期試驗的大量分子是這種下降的主要原因。
  • 在服務中，存儲和配送領域預計將增長最快，在預測期內復合年增長率為 6.8%。 全球生物製劑管道的不斷增長和溫度敏感藥物數量的增加預計將增加臨床試驗藥物物流的複雜性。
  • 由於遺傳學和生物技術領域的研究不斷增加，例如基於納米顆粒的藥物輸送系統的開發，預計生物製劑在預測期內將以 6.7% 的複合年增長率增長最快。
  • 在治療應用中，腫瘤學在 2022 年佔據市場主導地位，收入份額為 38.8%。 據合眾社國際報導，美國醫院因管理不當而丟棄了數十億瓶抗癌藥物，凸顯了適當供應管理的必要性。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 區域範圍
  • 估計/預測時間表
  • 目的
  • 調查方法
  • 信息獲取
  • 信息或數據分析
  • 市場形成和驗證
  • 型號詳細信息
  • 輔助信息列表
  • 縮寫列表

第 2 章執行摘要

  • 市場前景
  • 分部展望
  • 競爭考慮因素

第 3 章臨床試驗用品市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/補充市場前景
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 臨床試驗用品市場分析工具
    • 行業分析-波特分析
    • PESTEL 分析
    • COVID-19 感染的影響分析

第四章臨床試驗用品市場：臨床階段估計和趨勢分析

  • 臨床試驗用品市場（按臨床階段）：細分儀表板
  • 臨床試驗用品市場（按臨床階段）：變異分析
    • 第一階段
    • 第二階段
    • 第三階段
    • 第四階段
    • 其他

第五章臨床試驗用品市場：產品和服務的估算和趨勢分析

  • 臨床試驗用品市場（按產品和服務）：細分儀表板
  • 臨床試驗用品市場（按產品和服務）：變化分析
    • 製造業
    • 存儲和分發
    • 供應鏈管理

第六章臨床試驗用品市場：治療領域預估及趨勢分析

  • 臨床試驗用品市場，按治療領域：細分儀表板
  • 臨床試驗用品市場，按治療領域：變化分析
    • 腫瘤學
    • 中樞神經系統
    • 心血管
    • 感染
    • 代謝紊亂
    • 其他

第七章臨床試驗用品市場：最終用途估計和趨勢分析

  • 臨床試驗用品市場，按最終用途：細分儀表板
  • 臨床試驗用品市場，按最終用途：變化分析
    • 藥品
    • 生物製品
    • 醫療設備
    • 其他

第八章臨床試驗用品市場：區域估算和趨勢分析

  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 北美
    • 2018-2030 年市場預估和預測（收入）
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳大利亞
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 9 章競爭格局

  • 市場進入者分類
    • 創新者
    • 市場領導者
    • 新興玩家
    • 2022 年公司市場份額分析
  • 公司簡介
    • Almac Group
    • Biocair
    • Catalent, Inc.
    • KLIFO
    • Movianto
    • PCI Pharma Services
    • Sharp Services, LLC
    • Thermo Fisher Scientific, Inc.
    • Marken
    • Paraxel International Corporation
Product Code: GVR-1-68038-514-4

Clinical Trial Supplies Market Growth & Trends

The global clinical trial supplies market size is expected to reach USD 3.4 billion by 2030, expanding at 6.5% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.

Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during the forecast period.

For instance, in 2022, Novartis invested around USD 10 billion in research and development. It also secured 23 approvals in the European Union, Japan, China, and the U.S. for new drugs and rare diseases. The company is also conducting 44 ongoing phase III programs in India with 17 clinical programs running in rare diseases such as atypical hemolytic uremic syndrome (aHUS), Immune thrombocytopenic purpura (ITP), spinal muscular atrophy (SMA), and Lupus Nephritis.

Direct-to-Patients (DTP) is an upcoming segment in the distribution of clinical trial supplies, which is expected to be the future model of distribution. DTP is one of the emerging models that involves delivering drugs to patients directly to create patient-centric trials. This would facilitate fewer visits to the site and reduce the burden on participants. The COVID-19 outbreak has led to the increased adoption of such a model, to continue clinical trial studies with minimum disruption. In addition, patient retention and a diverse pool of patients worldwide are some of the notable reasons that can be attributed to the high adoption of this model.

Clinical Trial Supplies Market Report Highlights

  • Based on the clinical phase, the market is anticipated to be dominated by the Phase III trial segment with a 52.7% revenue share in 2022. The presence of a large number of molecules currently under Phase III makes it the primary factor responsible for this deduction
  • Among services, the storage, and distribution segment is anticipated to witness the fastest growth at a CAGR of 6.8% during the forecast period. The rise in global biologics pipeline and temperature-sensitive drugs is expected to increase the complexities related to the logistics of clinical trial supplies
  • Biologics are expected to witness the fastest growth at 6.7% CAGR during the forecast period owing to the increasing research in the field of genetics and biotechnology such as the development of nanoparticle-based drug delivery systems
  • In terms of therapeutic use, oncology dominated the market with a revenue share of 38.8% in 2022. According to the United Press International, hospitals in the U.S. are disposing of billions of cancer drug vials due to improper dosage, thereby indicating the need for appropriate supply management

Table of Contents

Chapter 1. Research Methodology And Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Clinical Phase
    • 1.1.3. Product & Services
    • 1.1.4. End Use
    • 1.1.5. Therapeutic Area
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. Parent Market Analysis
  • 1.10. List Of Secondary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trial Supplies Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion of clinical trials sites
      • 3.2.1.2. Growing R&D in biologics and biosimilar
      • 3.2.1.3. Advancements in supply chain technology
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Presence of stringent regulatory policies
      • 3.2.2.2. High Possibility of Counterfeiting Drugs
  • 3.3. Clinical Trial Supplies Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Clinical Trial Supplies Market: Clinical Phase Estimates & Trend Analysis

  • 4.1. Clinical Trial Supplies Market, By Clinical Phase: Segment Dashboard
  • 4.2. Clinical Trial Supplies Market, By Clinical Phase: Movement Analysis
  • 4.3. Clinical Trial Supplies Market Estimates & Forecasts, By Clinical Phase, 2018 - 2030
    • 4.3.1. Phase I
      • 4.3.1.1. Phase I Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 4.3.2. Phase II
      • 4.3.2.1. Phase II Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 4.3.3. Phase III
      • 4.3.3.1. Phase III Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 4.3.4. Phase IV
      • 4.3.4.1. Phase IV Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 4.3.5. Others
      • 4.3.5.1. Others market, 2018 to 2030 (USD Billion)

Chapter 5. Clinical Trial Supplies Market: Product & Service Estimates & Trend Analysis

  • 5.1. Clinical Trial Supplies Market, By Product & Service: Segment Dashboard
  • 5.2. Clinical Trial Supplies Market, By Product & Service: Movement Analysis
  • 5.3. Clinical Trial Supplies Market Estimates & Forecasts, By Product & Service, 2018 - 2030
    • 5.3.1. Manufacturing
      • 5.3.1.1. Manufacturing Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 5.3.2. Storage & Distribution
      • 5.3.2.1. Storage & Distribution Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 5.3.3. Supply Chain Management
      • 5.3.3.1. Supply Chain Management Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)

Chapter 6. Clinical Trial Supplies Market: Therapeutic Area Estimates & Trend Analysis

  • 6.1. Clinical Trial Supplies Market, By Therapeutic Area: Segment Dashboard
  • 6.2. Clinical Trial Supplies Market, By Therapeutic Area: Movement Analysis
  • 6.3. Clinical Trial Supplies Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030
    • 6.3.1. Oncology
      • 6.3.1.1. Oncology clinical trial supplies market 2018 to 2030 (USD Billion)
    • 6.3.2. CNS
      • 6.3.2.1. CNS clinical trial supplies market 2018 to 2030 (USD Billion)
    • 6.3.3. Cardiovascular
      • 6.3.3.1. Cardiovascular clinical trial supplies market 2018 to 2030 (USD Billion)
    • 6.3.4. Infectious disease
      • 6.3.4.1. Infectious disease clinical trial supplies market 2018 to 2030 (USD Billion)
    • 6.3.5. Metabolic disorders
      • 6.3.5.1. Metabolic Disorders Clinical Trial Supplies Market, 2018 to 2030 (USD Billion)
    • 6.3.6. Others
      • 6.3.6.1. Others clinical trial supplies market 2018 to 2030 (USD Billion)

Chapter 7. Clinical Trial Supplies Market: End-use Estimates & Trend Analysis

  • 7.1. Clinical Trial Supplies Market, By End-use: Segment Dashboard
  • 7.2. Clinical Trial Supplies Market, By End-use: Movement Analysis
  • 7.3. Clinical Trial Supplies Market Estimates & Forecasts, By End-use, 2018 - 2030
    • 7.3.1. Pharmaceutical
      • 7.3.1.1. Pharmaceutical Clinical trial supplies market 2018 to 2030 (USD Billion)
    • 7.3.2. Biologics
      • 7.3.2.1. Biologics clinical trial supplies market 2018 to 2030 (USD Billion)
    • 7.3.3. Medical Devices
      • 7.3.3.1. Medical devices clinical trial supplies market 2018 to 2030 (USD Billion)
    • 7.3.4. Others
      • 7.3.4.1. Others clinical trial supplies market 2018 to 2030 (USD Billion)

Chapter 8. Clinical Trial Supplies Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2022 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. North America
    • 8.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Billion)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. U.S. market estimates and forecasts, 2018 - 2030
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Canada market estimates and forecasts, 2018 - 2030
  • 8.5. Europe
    • 8.5.1. UK
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Competitive scenario
      • 8.5.1.3. Regulatory framework
      • 8.5.1.4. UK market estimates and forecasts, 2018 - 2030
    • 8.5.2. Germany
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Germany market estimates and forecasts, 2018 - 2030
    • 8.5.3. France
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. France market estimates and forecasts, 2018 - 2030
    • 8.5.4. Italy
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Italy market estimates and forecasts, 2018 - 2030
    • 8.5.5. Spain
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Spain market estimates and forecasts, 2018 - 2030
    • 8.5.6. Denmark
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Denmark market estimates and forecasts, 2018 - 2030
    • 8.5.7. Sweden
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Sweden market estimates and forecasts, 2018 - 2030
    • 8.5.8. Norway
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Norway market estimates and forecasts, 2018 - 2030
  • 8.6. Asia Pacific
    • 8.6.1. Japan
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Competitive scenario
      • 8.6.1.3. Regulatory framework
      • 8.6.1.4. Japan market estimates and forecasts, 2018 - 2030
    • 8.6.2. India
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. India market estimates and forecasts, 2018 - 2030
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. China market estimates and forecasts, 2018 - 2030
    • 8.6.4. South Korea
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. South Korea market estimates and forecasts, 2018 - 2030
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. Australia market estimates and forecasts, 2018 - 2030
    • 8.6.6. Thailand
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Regulatory framework
      • 8.6.6.4. Thailand market estimates and forecasts, 2018 - 2030
  • 8.7. Latin America
    • 8.7.1. Brazil
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Competitive scenario
      • 8.7.1.3. Regulatory framework
      • 8.7.1.4. Brazil market estimates and forecasts, 2018 - 2030
    • 8.7.2. Mexico
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Mexico Market estimates and forecasts, 2018 - 2030
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Argentina market estimates and forecasts, 2018 - 2030
  • 8.8. MEA
    • 8.8.1. South Africa
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Competitive scenario
      • 8.8.1.3. Regulatory framework
      • 8.8.1.4. South Africa market estimates and forecasts, 2018 - 2030
    • 8.8.2. Saudi Arabia
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Regulatory framework
      • 8.8.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 8.8.3. UAE
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. UAE market estimates and forecasts, 2018 - 2030
    • 8.8.4. Kuwait
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Innovators
    • 9.1.2. Market Leaders
    • 9.1.3. Emerging Players
    • 9.1.4. Company Market Share Analysis, 2022
  • 9.2. Company Profiles
    • 9.2.1. Almac Group
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Service benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Biocair
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Service benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Catalent, Inc.
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Service benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. KLIFO
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Service benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Movianto
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Service benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. PCI Pharma Services
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Service benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Sharp Services, LLC
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Service benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Thermo Fisher Scientific, Inc.
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Service benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Marken
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Service benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Paraxel International Corporation
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Service benchmarking
      • 9.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 3 North America clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 4 North America clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 5 North America clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 6 US clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 7 US clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 8 US clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 9 US clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 10 Canada clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 11 Canada clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 12 Canada clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 13 Canada clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 14 Europe clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 15 Europe clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 16 Europe clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 17 Europe clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 18 UK clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 19 UK clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 20 UK clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 21 UK clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 22 Germany clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 23 Germany clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 24 Germany clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 25 Germany clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 26 France clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 27 France clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 28 France clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 29 France clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 30 Italy clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 31 Italy clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 32 Italy clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 33 Italy clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 34 Spain clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 35 Spain clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 36 Spain clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 37 Spain clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 38 Denmark clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 39 Denmark clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 40 Denmark clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41 Denmark clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 42 Sweden clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 43 Sweden clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 44 Sweden clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 45 Sweden clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 46 Norway clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 47 Norway clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 48 Norway clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 49 Norway clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 53 Asia Pacific clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 54 Japan clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 55 Japan clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 56 Japan clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 57 Japan clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 58 China clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 59 China clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 60 China clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 61 China clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 62 India clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 63 India clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 64 India clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 65 India clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 66 Australia clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 67 Australia clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 68 Australia clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 69 Australia clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 70 South Korea clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 71 South Korea clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 72 South Korea clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 73 South Korea clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 74 Thailand clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 75 Thailand clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 76 Thailand clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 77 Thailand clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 78 Latin America clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 79 Latin America clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 80 Latin America clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 81 Latin America clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 82 Brazil clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 83 Brazil clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 84 Brazil clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 85 Brazil clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 86 Mexico clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 87 Mexico clinical trials supply chain management market, by type, 2018 - 2030 (USD Billion)
  • Table 88 Mexico clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 89 Mexico clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 90 MEA clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 91 MEA clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 92 MEA clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 93 MEA clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 94 South Africa clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 95 South Africa clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 96 South Africa clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 97 South Africa clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 98 Saudi Arabia clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 99 Saudi Arabia clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 100 Saudi Arabia clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 101 Saudi Arabia clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 102 UAE clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 103 UAE clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 104 UAE clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 105 UAE clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)
  • Table 106 Kuwait clinical trial supplies market, by product and services, 2018 - 2030 (USD Billion)
  • Table 107 Kuwait clinical trial supplies market, by end-use, 2018 - 2030 (USD Billion)
  • Table 108 Kuwait clinical trial supplies market, by therapeutics use, 2018 - 2030 (USD Billion)
  • Table 109 Kuwait clinical trial supplies market, by clinical phases, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market summary (Figures in USD Billion, 2022)
  • Fig. 8 Market trends & outlook
  • Fig. 9 Clinical trial supplies market: Market segmentation
  • Fig. 10 Clinical trial supplies market revenue, (USD Billion), 2018 - 2030
  • Fig. 11 Clinical trial supplies: Porter's analysis
  • Fig. 12 Clinical trial supplies: PESTEL analysis
  • Fig. 13 Clinical trial supplies market phase outlook key takeaways
  • Fig. 14 Clinical trial supplies market: Phase movement analysis
  • Fig. 15 Phase I market, 2018 - 2030 (USD Billion)
  • Fig. 16 Phase II market, 2018 - 2030 (USD Billion)
  • Fig. 17 Phase III market, 2018 - 2030 (USD Billion)
  • Fig. 18 Others market, 2018 - 2030 (USD Billion)
  • Fig. 19 Clinical trial supplies market product/service outlook key takeaways
  • Fig. 20 Clinical trial supplies market: Product/Service movement analysis
  • Fig. 21 Manufacturing market, 2018 - 2030 (USD Billion)
  • Fig. 22 Storage & distribution market, 2018 - 2030 (USD Billion)
  • Fig. 23 Cold chain-based storage & distribution market, 2018 - 2030 (USD Billion)
  • Fig. 24 Non-cold chain-based storage & distribution market, 2018 - 2030 (USD Billion)
  • Fig. 25 Supply chain management market, 2018 - 2030 (USD Billion)
  • Fig. 26 Clinical trial supplies market end-use outlook key takeaways
  • Fig. 27 Clinical trial supplies market: End-use movement analysis
  • Fig. 28 Pharmaceuticals market, 2018 - 2030 (USD Billion)
  • Fig. 29 Biologics market, 2018 - 2030 (USD Billion)
  • Fig. 30 Medical device market, 2018 - 2030 (USD Billion)
  • Fig. 31 Other end-use market, 2018 - 2030 (USD Billion)
  • Fig. 32 Clinical trial supplies market therapeutic use outlook key takeaways
  • Fig. 33 Clinical trial supplies market: Therapeutic Use movement analysis
  • Fig. 34 Oncology market, 2018 - 2030 (USD Billion)
  • Fig. 35 CNS market, 2018 - 2030 (USD Billion)
  • Fig. 36 Cardiovascular market, 2018 - 2030 (USD Billion)
  • Fig. 37 Infectious disease market, 2018 - 2030 (USD Billion)
  • Fig. 38 Metabolic disorders market, 2018 - 2030 (USD Billion)
  • Fig. 39 Other therapeutic use market, 2018 - 2030 (USD Billion)
  • Fig. 40 Regional marketplace: Key takeaways
  • Fig. 41 North America clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 42 U.S. clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 43 Canada clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 44 Europe clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 45 UK clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 46 Germany clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 47 France clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 48 Italy clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 49 Spain clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 50 Denmark clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 51 Sweden clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 52 Norway clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 53 Asia Pacific clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 54 Japan clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 55 China clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 56 India clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 57 Australia clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 58 South Korea clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 59 Thailand clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 60 Latin America clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 61 Brazil clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 62 Mexico clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 63 Argentina clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 64 MEA clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 65 South Africa clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 66 Saudi Arabia clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 67 UAE clinical trial supplies market, 2018 - 2030 (USD Billion)
  • Fig. 68 Kuwait clinical trial supplies market, 2018 - 2030 (USD Billion)